Firsocostat is an acetyl-CoA carboxylase inhibitor that functions in the liver. Its original designation was GS-0976. It was discovered by Nimbus Therapeutics. The drug is under development by Gilead as a treatment for non-alcoholic fatty liver disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.